Výsledky vyhledávání

Akademický článek

Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies

Autor: Hanania NA, Yohannes AM, Ozol-Godfrey A, Tocco M, Goodin T, Sharma S, Sanjar S

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 865-875 (2021)

Nicola A Hanania,1 Abebaw M Yohannes,2 Ayca Ozol-Godfrey,3 Michael Tocco,3 Thomas Goodin,3 Sanjay Sharma,3 Shahin Sanjar3 1Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, 77030, USA; 2Department of Phy

Externí odkaz: https://doaj.org/article/f7388cdd9c8447a9ab3dec858e4451a9

Zobrazit plný text záznamu

Akademický článek

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

Autor: Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 995-1004 (2020)

Jill A Ohar,1 Ayca Ozol-Godfrey,2 Thomas Goodin,2 Shahin Sanjar2 1Department of Internal Medicine, Wake Forest University, Winston-Salem, NC, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USACorrespondence: Jill A OharDepartment of Internal M

Externí odkaz: https://doaj.org/article/794981da1a5a4e9dad7ad14b96459c14

Zobrazit plný text záznamu

Akademický článek

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies

Autor: Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 745-754 (2020)

James F Donohue,1 Ayca Ozol-Godfrey,2 Thomas Goodin,2 Shahin Sanjar2 1Department of Pulmonary Diseases and Critical Care Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA,

Externí odkaz: https://doaj.org/article/d7c7bf61df644c089316ecd03a7cc7aa

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies

Autor: Ohar JA, Bowling A, Goodin T, Price B, Ozol-Godfrey A, Sharma S, Sanjar S

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 461-470 (2019)

Jill A Ohar,1 Alyssa Bowling,2 Thomas Goodin,2 Barry Price,2 Ayca Ozol-Godfrey,2 Sanjay Sharma,2 Shahin Sanjar2 1Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA; 2Sunovion Pharmaceuticals Inc, Marlborough, MA,

Externí odkaz: https://doaj.org/article/37420eaf31d24de69b0cf0716e9fb8f0

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

Autor: Ohar J, Tosiello R, Goodin T, Sanjar S

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 27-37 (2018)

Jill Ohar,1 Robert Tosiello,2 Thomas Goodin,2 Shahin Sanjar2 1Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USA Background: The efficacy and safety

Externí odkaz: https://doaj.org/article/e06d993eed024c769f24cc95de89a753

Zobrazit plný text záznamu

Akademický článek

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Autor: Kerwin EM, Tosiello R, Price B, Sanjar S, Goodin T

Publikováno v: International Journal of COPD, Vol Volume 13, Pp 2917-2929 (2018)

Edward M Kerwin,1 Robert Tosiello,2 Barry Price,2 Shahin Sanjar,2 Thomas Goodin2 1Clinical Research Institute of Southern Oregon, Inc., Medford, OR, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USA Background: Phase III studies demonstrated

Externí odkaz: https://doaj.org/article/c79f98322aff46f88413b58d63a440e2

Zobrazit plný text záznamu

Akademický článek

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]

Autor: Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 1347-1348 (2021)

Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S. Int J Chron Obstruct Pulmon Dis. 2020;15:995–1004. The authors have advised there is an error in Figure 4B on page 1000. For EXACT-RS responder rates, the OR for both genders are shown to be significant

Externí odkaz: https://doaj.org/article/edfcb55b77d84a44960aa49d631aeafd

Zobrazit plný text záznamu